BIOGRAPHIES

LAB MMX SPEAKER BIOGRAPHIES

Northeast Region Conference 2010

Tuesday, April 13th Program:

Management

Jeff Jacobs is associate executive director for special programs, Association of Public Health Laboratories and vice president of Public Policy, American Society for Clinical Pathology (ASCP).

Lucia Berte is a consultant with Laboratories Made Better! P.C. in Broomfield Colorado. She is health care professional who has specialized in quality management systems in health care ancillary services for almost 20 years, She is committed to reducing laboratory problems that affect quality and patient safety.

P. Thomas Hirsch has had extensive experience in the management and operations of hospital and independent laboratories. He is currently co-founder and president of Laboratory Billing Solutions, a company that performs billing services for hospital outreach and smaller independent laboratories. He was president and chief executive officer of Path Lab Inc. from June 1984 through February 2003, a highly successful hospital-based independent laboratory. The company was sold to LabCorp in April 2001 for more than $100 million

Quality

Charity M. Robbins CPC, CMPAM is Manager, BRL Revenue Cycle

Jason Newmark is Director, Diagnostic Services Baystate Health, Springfield Massachusetts

Glenn Surprenant is Senior Manager Diagnostic Services Baystate Medical Center, Springfield Massachusetts

Sharon Scott is Quality Management Coordinator, Baystate Medical Center, Springfield Massachusetts

Marketing & Planning

Daniella Priebatsch has been a member of the Google AdWords division for three years. As an AdWords Account Manager, Daniella helps Healthcare companies develop strategic integrated marketing plans that support their online and offline advertising goals. Prior to joining Google, Danielle graduated with a BA in American Studies from Brown University.

Microchip Diagnostics

Anubhave Tripathi, Ph.D., is an associate professor in the division of engineering and the division of biological sciences and medical school (courtesy) at Brown University. His experience in research and development builds from six years at Brown University as faculty, three years at Caliper LifeSciences (Hopkinton, MA) as a research scientist, a year at San Jose State University as a part-time instructor, two years at Massachusetts Institute of Technology (MIT) as a postdoctoral associate and five years at the Levich Institute, City University of New York as a graduate student. At Brown, he also serves as co-director of the center for biomedical engineering. His research thrust is in biomedical engineering particularly focusing on disease detection and diagnostics through translational research. His current research collaborations with Memorial Hospital on influenza subtype detection, with Miriam Hospital on K103N HIV detection, with Rhode Island Hospital on Clostridium difficile, and with Women and Infants Hospital on 3D culture for in-vitro fertilization

Autoimmune Disease

Eric S. Hoy Ph.D., earned his degree in Pathology from the University of Illinois College of Medicine in Chicago. He has been involved in Laboratory Medicine and Pathology for over 30 years. Dr. Hoy is currently a Clinical Associate Professor at the University of Texas Southwestern Medical Center at Dallas, where he teaches Basic Immunology, Clinical Immunology, and Molecular Biology in the Department of Medical Laboratory Sciences. Dr. Hoy's major interest in the field of Clinical Immunology is Autoimmune Diseases.

Emerging Technologies

Chris Williams currently Product Specialist at PerkinElmer Health Sciences, first worked at both Schering-Plough and Sandoz Pharmaceuticals in their respective Tumor Biology programs after graduate school. In 1996 he moved to Millennium Pharmaceuticals working in both Technology Development and Proteomic groups where he focused on using label free technologies for studying protein-protein interactions and protein-drug interactions.. After working for two start-up companies he moved to PerkinElmer in 2005 and held positions in the Applications Group, R&D, and currently in sales as the North American Product Specialist in Maternal Fetal Health.

Scott Kuzdzal, Ph.D. received his Ph.D. in Analytical Chemistry in 1997 from the University of California at Riverside. He served as a postdoctoral fellow at the Johns Hopkins University School of Medicine, where he co-founded and directed the Johns Hopkins Center for Biomarker Discovery with Dr. Daniel Chan. He has extensive industrial research experience, managing the serum and membrane proteomics groups at Celera, working in senior scientist and technology leader roles at PerkinElmer and Life Science business manager at Shimadzu. He also has a strong clinical chemistry background and has directed Toxicology and Therapeutic Drug Monitoring Labs at Johns Hopkins Medical Institutions. He currently serves on the editorial review board of Proteomics and hosts the USHUPO website (USHUPO.org). He has published protein and peptide biomarkers for pancreatic cancer (HIPAP1), Alzheimer's disease and ovarian cancer using a wide variety of separation and detection methods. Scott has lectured at continuing medical education courses at Johns Hopkins Hospital, George Mason University/INOVA Fairfax Hospital and the NIH, as well as conferences worldwide. He has co-authored several proteomics book chapters and has multiple patents. Scott currently serves as the Life Science Business Manager for Biotech Products at Shimadzu Scientific Instruments

Salvatore J Salamone, Ph.D. has over 25 years experience in the health care and medical device industries. Prior to founding Saladax, Dr Salamone was Vice President of Research and Development, Roche Diagnostics, where he was responsible for North American research and development efforts for the Laboratory Systems Division. Dr Salamone's efforts during his 17-year tenure at Roche resulted in the launch of 7 major reagent product platforms, comprised of over 70 products and more than 200 instrument applications. Dr Salamone is well known in the field of drug management with well over 100 publications, including textbook chapters, books, patents, and articles in the area. Dr. Salamone received 2 bachelor's degrees from Villanova University, a master's and a Ph.D. degree from Rutgers University, and was a SERC Post-Doctoral Fellow at Oxford University.

Raymond Y Kwong MD MPH FACC, is Director of Cardiac Magnetic Resonance Imaging, Brigham and Women's Hospital, Boston, MA., and Assistant Professor of Medicine Harvard Medical School. He earned his undergraduate degree in Chemistry from the University of Toronto in 1988. He graduated from Medical School at the University of Toronto in 1992. He did his internship at St. Josephs Health Center, University of Toronto and his residency at Vancouver General Hospital, University of British Columbia. He completed a Cardiovascular Fellowship at George Washington University Medical Center and a Post Doc Fellowship at the National Institutes of Health.

Phlebotomy/Emerging Technologies

Jonathan Park, Ph.D., CG(ASCP)CM is the AGT Representative to the ASCP Board of Certification (BOC) Board of Governors

Lori Zanin, MLS (ASCP) is the Laboratory Manager at Milton Hospital, a clinical affiliate of Beth Israel Deaconess Medical Center in Milton, Massachusetts. Lori also served as Chemistry and Hematology Section Head at Memorial Hospital of Rhode Island. Lori has been working the turn around time of AM draws as a performance improvement initiative for the last three years.

Dr. Stacy E.F. Melanson received her MD and PhD from Tufts University School of Medicine in Boston, MA. She completed her residency in Clinical Pathology at Massachusetts General Hospital in Boston, MA. She is currently an Assistant Professor of Pathology at Harvard Medical School and the Associate Medical Director of Clinical Chemistry, the Medical Director of Phlebotomy, the Medical Director of the BWH Laboratory at BWH/Mass General Health Care Center and the Medical Director of Point of Care Testing at Brigham and Women's Hospital in Boston, MA. She is actively involved in ongoing projects related to process improvement in phlebotomy such as improvement of inpatient phlebotomy rounding and communication, benefits of electronic positive patient identification and implementation of an electronic system to communicate physician orders with the laboratory information system. Her most recent article on process improvement, which describes new workflow for outpatient phlebotomy services, is in press in the American Journal of Clinical Pathology

John P. Hickey, MD, joined Monogram Biosciences in July, 2008 as Regional Director in the Medical Affairs department. He is responsible for clinical research and education in oncology and virology for the Northeast Region of the United States.
Dr. Hickey attended the State University of Stony Brook, School of Medicine and had his post-graduate training in internal medicine and pediatrics at St. Vincent's Hospital in New York City. He is board certified in internal medicine and pediatrics.
Before coming to Monogram, Dr. Hickey practiced HIV medicine, primary care medicine and addiction medicine at Bronx-Lebanon Hospital in New York City. His other clinical appointments after residency were at Metropolitan Hospital in New York City, where he had an academic appointment at New York Medical College as assistant professor in internal medicine and pediatrics, and Callen-Lorde Community Health Center in New York City. He is currently pursuing a Masters in Public Health

Dawn Robertson, MT(ASCP)SH, her career has been in the clinical laboratory until a recent career change to join the Beckman Coulter team. She have been a Hematology tech, Hematology Supervisor, Laboratory Supervisor and most recently a Laboratory Manager. She went to school at the University of Nebraska, where studying and attending football games, of course, were the top priorities (Go Big Red!) The majority of her career has been in Colorado where she have been involved in supporting Clinical Lab Science in a number of capacities over the years. She pursued her Specialist in Hematology because she has always loved learning, teaching and simply enjoying the fascinating aspects of Hematology and medicine in general.

EVENING DINNER AND LECTURE

Daniel W. Chan, Ph.D., DABCC, FACB, is the Director of the Clinical Chemistry Division and Co-Director of the Pathology Core Lab of the Johns Hopkins Hospital and Professor of Pathology, Oncology, Radiology, and Urology and the Director of the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine. He has served on the Board of Directors of the National Academy of Clinical Biochemistry, President of the National Registry in Clinical Chemistry and the Chair of the Proteomics Division in the American Association for Clinical Chemistry. He is a founder and a member of the Board of Directors of USHUPO. He is a senior editor of Cancer Epidemiology Biomarkers & Prevention and the Editor-in-Chief of Clinical Proteomics. Dr. Chan is an internationally recognized expert on clinical proteomics, biochemical tumor markers, and immunoassay. Dr. Chan has edited and written 5 books on tumor markers, immunoassay and automation and published over 250 scientific articles.

Wednesday, April 14th Program:

Management

Paul D. Camara, MS, is the Vice President , Clinical consulting, Applied Management Systems, Inc in Burlington Ma. He brings over 25 years of progressive healthcare management experience to AMS. His expertise includes direction of clinical laboratories as well as diagnostic imaging, cardiology, and radiation oncology departments.

Sharon Brommer, MS, MBA FACHE, is a senior manager at Applied Management Systems, inc., Burlington, Massachusetts

Quality

Dan Jones MD, PhD is Director, Esoteric Anatomic Pathology (EAP)/Medical Director, Hematopathology, Quest Diagnostics (Chantilly VA) and Professor, School of Health Sciences (Adjunct), M.D. Anderson Cancer Center.

Nancy Smith is Senior Director of Patient Care Howard County General Hospital, part of John Hopkins Medicine

Jan Krouwer, PhD has over 30 years experience in the IVD industry, where he has provided evaluation and reliability protocols and analyses for Ciba-Corning and other companies. He has also contributed to CLSI (formerly NCCLS) as chair of the Area Committee on Evaluation Protocols and chair of several subcommittees including EP18 (risk management), EP27 (error grids) and EP21 (total error). He also has a blog about clinical laboratory quality at http://jkrouwer.wordpress.com/.

Mary Ellen Cortizas, PBT(ASCP), JD Administrative Director of Laboratory Medicine

Lori Zanin , MLS (ASCP) is the Laboratory Manager at Milton Hospital, a clinical affiliate of Beth Israel Deaconess Medical Center in Milton, Massachusetts. Lori also served as Chemistry and Hematology Section Head at Memorial Hospital of Rhode Island. Lori has been working the turn around time of AM draws as a performance improvement initiative for the last three years.

Stacey Melanson received her MD and PhD from Tufts University School of Medicine in Boston, MA. She completed her residency in Clinical Pathology at Massachusetts General Hospital in Boston, MA. She is currently an Assistant Professor of Pathology at Harvard Medical School and the Associate Medical Director of Clinical Chemistry, the Medical Director of Phlebotomy, the Medical Director of the BWH Laboratory at BWH/Mass General Health Care Center and the Medical Director of Point of Care Testing at Brigham and Women's Hospital in Boston, MA. She is actively involved in ongoing projects related to process improvement in phlebotomy such as improvement of inpatient phlebotomy rounding and communication, benefits of electronic positive patient identification and implementation of an electronic system to communicate physician orders with the laboratory information system. Her most recent article on process improvement, which describes new workflow for outpatient phlebotomy services, is in press in the American Journal of Clinical Pathology

Mary Ellen Cortizas, PBT(ASCP), JD is Administrative Director of Laboratory Medicine at Children's Hospital Boston, and teaches the Laboratory Management course in Northeastern's Clinical Laboratory Science program

POCT WORKSHOP: How Do We Achieve Concordance
Between POCT and Central Lab Test Results

Jeffrey A. DuBois, Ph.D. FACB is Vice President of Medical and Scientific Affairs at Nova Biomedical in Waltham Massachusetts.

William A. Clarke, Ph.D., MBA, DABCC is Assistant Professor and Director Point of Care Testing and TDM Toxicology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore Maryland.

Martha E Lyon, Ph.D., DABCC, FACB Is Section Head for Neonatal and Pediatric Clinical Biochemistry and Point of Care Testing, Alberta Children's Hospital, Calgary, Alberta Canada. She is also Associate Professor Departments of Pathology and Laboratory Medicine, Pharmacology and Physiology, and Pediatrics, University of Calgary, Calgary, Alberta, Canada.

Biomarkers

Geralyn M Lambert-Messerlian, Ph.D. is Associate Director Division of Prenatal and Special Testing Women and infants Hospital, Providence RI. She is also Associate Professor in Pathology and Laboratory Medicine, Brown University School of Medicine.

Emerging Technologies

Narasimhan Nagan, Ph.D., FACMG, DABCC received his PhD at Boston University, followed by fellowship training in clinical molecular genetics and clinical chemistry at the Mayo Clinic, Rochester, MN. He is board-certified in clinical molecular genetics, clinical chemistry and molecular diagnostics and holds a New York State Director Certificate in genetic testing, molecular oncology, clinical chemistry and diagnostic immunology.

Jeffrey Chance, Ph.D. is currently a Senior Clinical Scientist in the Medical & Scientific Affairs and Clinical Operations department of BD Diagnostics - Preanalytical Systems. In this role, he is responsible for leading clinical evaluations of blood collection tubes, including risk assessments for new technologies and material changes, design of clinical testing plans, and managing clinical trials from initial feasibility studies through validation and regulatory submission. Dr. Chance joined BD after completing the Clinical Chemistry Postdoctoral Training Program at the Johns Hopkins Medical Institutions in 1999. He received his Ph.D. in Analytical Chemistry from McGill University in 1997

Michael Astion, MD, PhD is currently a clinical pathologist who is a Professor in the University of Washington Department of Laboratory Medicine. He received his M.D. and Ph.D. degrees from the University of Pennsylvania under the auspices of the NIH Medical Scientist Training Program. He has been on the faculty at the University of Washington since 1993. He has authored 20 educational software titles, including ANA-Tutor, and more than 40 peer-reviewed papers. The software titles serve as the basis of a university-sponsored company and learning system known as Medical Training Solutions, which is the 2nd leading provider of PACE credits in the United States . He is a frequent speaker at Grand Rounds and at professional meetings where he lectures on issues related to autoantibody testing, laboratory utilization, test interpretation, and competency assessment. For his contributions to laboratory quality, Dr. Astion was awarded the 2006 AACC Annual Award for Outstanding Clinical Laboratory Contributions to Patient Safety. In 2007, he was awarded the Annual Canadian Traveling Lectureship from the Canadian Society of Clinical Chemists. In 2008, he was the recipient of the AACC Management Science Division Annual Award for Outstanding Contributions to Laboratory Management.

Denise L. Uettwiller-Geiger, PhD, MT(ASCP), DLM(ASCP), is Director of Laboratories, Director of Clinical Research, and a Clinical Chemist in the Clinical Laboratories of John T. Mather Memorial Hospital (Port Jefferson, NY). She has authored articles, abstracts, and book chapters on subjects including laboratory management, laboratory automation, patient safety, cardiac markers, endocrinology, and immunoassays. She is a Past President for the Clinical Ligand Society, and in 2001 was nominated for the Woman of Distinction Award from the First Senate District in New York State. Her clinical research interests have focused in the areas of infectious disease, cardiac markers, and fertility. She has served as principal investigator for numerous clinical trials.

Phlebotomy

Kathleen Finnegan M.S. MT(ASCP)SH, holds the title of Clinical Associate Professor in the department of Clinical Laboratory Sciences at Stony Brook University of New York. She received her bachelor degree from SUNY@ Stony Brook in Clinical Laboratory Sciences and her master's degree from C.W. Post in Medical Biology. Her many years of clinical experience were at a small community hospital. She has 20 years of teaching and is the chair of the Clinical Laboratory Sciences program. She is board certified with the American Society of Clinical Pathologists (ASCP) and has her specialist in hematology (SH). Other accomplishments include, she has been a contributor of chapters in "Saunders Manual of Clinical Laboratory Sciences by Craig Lehmann, Hematology in Practice by Betty Ciesla, and Clinical Hematology and Fundamentals in Hemostasis by Denise Harmening. She also has published articles and case studies in field related journals and is an invited speaker for ASCP workshops. Her talks are at the local, state, national and international level. She also had the opportunity to teach phlebotomy in Africa.

Becky Socha works in clinical laboratory and nutritional sciences at the University of Massachusetts (Lowell Campus)